Form 4 for DERM Journey Medical Corp
Accepted 2024-03-25 00:00:00 ET · period of report 2024-03-22 · accession 0001104659-24-038437 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-25 | 2024-03-22 | DERM | Maraoui Claude | Pres, CEO, Dir | P - Purchase | $3.48 | +10.0K | 2.16M | +0.5% | +$34.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.0001 par value | 2024-03-22 | P | A | 10,000 | $3.48 | 2,163,430 | D | — | — | (F1) Reflects the weighted average purchase price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on March 22, 2024, was $3.41 to $3.48. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price. (F2) Includes restricted stock units, which vest over various time periods. |